302 related articles for article (PubMed ID: 28214218)
1. Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma.
Chen WJ; Gan TQ; Qin H; Huang SN; Yang LH; Fang YY; Li ZY; Pan LJ; Chen G
Pathol Res Pract; 2017 Apr; 213(4):364-372. PubMed ID: 28214218
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
5. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the HOXA11 level in patients with lung squamous cancer and insights into potential molecular pathways via bioinformatics analysis.
Zhang R; Zhang TT; Zhai GQ; Guo XY; Qin Y; Gan TQ; Zhang Y; Chen G; Mo WJ; Feng ZB
World J Surg Oncol; 2018 Jun; 16(1):109. PubMed ID: 29914539
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Ke D; Guo Q; Fan TY; Xiao X
Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
[No Abstract] [Full Text] [Related]
8. Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data.
Gan TQ; Xie ZC; Tang RX; Zhang TT; Li DY; Li ZY; Chen G
Tumour Biol; 2017 Mar; 39(3):1010428317691683. PubMed ID: 28347234
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-125b-5p and Its Prospective Molecular Mechanism in Lung Squamous Cell Carcinoma.
Huang SP; Jiang YF; Yang LJ; Yang J; Liang MT; Zhou HF; Luo J; Yang DP; Mo WJ; Chen G; Shi L; Gan TQ
Cancer Biother Radiopharm; 2022 Mar; 37(2):125-140. PubMed ID: 32614608
[No Abstract] [Full Text] [Related]
10. Identification of high expression profiles of miR-31-5p and its vital role in lung squamous cell carcinoma: a survey based on qRT-PCR and bioinformatics analysis.
Chi XJ; Wei LL; Bu Q; Mo N; Chen XY; Lan D; Zhou QN
Transl Cancer Res; 2019 Jun; 8(3):788-801. PubMed ID: 35116817
[TBL] [Abstract][Full Text] [Related]
11. [Identification of differentially expressed genes between lung adenocarcinoma and squamous cell carcinoma using transcriber signature analysis].
Peng S; Li X; Liu Q; Zhang Y; Zou L; Gong X; Wang M; Ma X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):641-649. PubMed ID: 31270041
[TBL] [Abstract][Full Text] [Related]
12. Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.
Wang J; Li Z; Ge Q; Wu W; Zhu Q; Luo J; Chen L
J Thorac Cardiovasc Surg; 2015 May; 149(5):1404-14.e4. PubMed ID: 25813410
[TBL] [Abstract][Full Text] [Related]
13. Machine learning identifies 10 feature miRNAs for lung squamous cell carcinoma.
Ye Z; Sun B; Xiao Z
Gene; 2020 Jul; 749():144669. PubMed ID: 32298761
[TBL] [Abstract][Full Text] [Related]
14. Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis.
Gan TQ; Chen WJ; Qin H; Huang SN; Yang LH; Fang YY; Pan LJ; Li ZY; Chen G
Med Sci Monit; 2017 May; 23():2453-2464. PubMed ID: 28533502
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
Sun F; Yang X; Jin Y; Chen L; Wang L; Shi M; Zhan C; Shi Y; Wang Q
Mol Med Rep; 2017 Jul; 16(1):609-616. PubMed ID: 28560415
[TBL] [Abstract][Full Text] [Related]
16. Expression of miR-486-5p and its significance in lung squamous cell carcinoma.
Yang S; Sui J; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
J Cell Biochem; 2019 Aug; 120(8):13912-13923. PubMed ID: 30963622
[TBL] [Abstract][Full Text] [Related]
17. Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.
Gao L; Zhang LJ; Li SH; Wei LL; Luo B; He RQ; Xia S
Pathol Res Pract; 2018 May; 214(5):732-749. PubMed ID: 29559248
[TBL] [Abstract][Full Text] [Related]
18. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Yang Y; Wang M; Liu B
J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
Chen YJ; Guo YN; Shi K; Huang HM; Huang SP; Xu WQ; Li ZY; Wei KL; Gan TQ; Chen G
Respir Res; 2019 Mar; 20(1):48. PubMed ID: 30832674
[TBL] [Abstract][Full Text] [Related]
20. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
Gao X; Wu Y; Yu W; Li H
Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
